162 results
Page 2 of 9
S-4/A
fz5dwb
18 Apr 23
Registration of securities issued in business combination transactions (amended)
4:01pm
8-K
EX-99.1
f4ovtkmjnu48 pro0yo
11 Apr 23
Adaptimmune and GSK Have Agreed Terms for Transfer of PRAME and NY-ESO Target Programs back to Adaptimmune
8:08am
8-K
EX-10.1
srin4y5hsmezyltrma
11 Apr 23
Adaptimmune and GSK Have Agreed Terms for Transfer of PRAME and NY-ESO Target Programs back to Adaptimmune
8:08am
8-K
wsyy6q xni0x
11 Apr 23
Adaptimmune and GSK Have Agreed Terms for Transfer of PRAME and NY-ESO Target Programs back to Adaptimmune
8:08am
S-4
th43xvj
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
8-K
EX-10.1
6prcx8v
20 Dec 22
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-10.1
qia72b2e4b 728oo2w
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am
424B5
mx87a5meol
28 Apr 22
Prospectus supplement for primary offering
8:09am